BindingDB logo
myBDB logout

38 articles for University of Tokyo


The following articles (labelled with PubMed ID or TBD) are for your review
PMIDArticle TitlePublishedDeposition
11259322 Carrier-mediated hepatobiliary transport of a novel antifolate, N-[4-[(2,4-dianninopteridine-6-yl)methyl]-3,4-dihydro-2H-1,4-benzothiazin-7-yl]carbonyl-L-homoglutamic acid, in rats. XX-APR-2001 30-AUG-2020
10997946 Selective inhibition of human cytochrome P450 3A4 by N-[2(R)-hydroxy-1(S)-indanyl]-5-[2(S)-(1, 1-dimethylethylaminocarbonyl)-4-[(furo[2, 3-b]pyridin-5-yl)methyl]piperazin-1-yl]-4(S)-hydroxy-2(R)-phenylmethy lpentanamide and P-glycoprotein by valspodar in gene transfectant systems. XX-OCT-2000 30-AUG-2020
15618649 The potential for an interaction between MRP2 (ABCC2) and various therapeutic agents: probenecid as a candidate inhibitor of the biliary excretion of irinotecan metabolites. XX-XXX-2002 30-AUG-2020
9262353 Kinetic analysis of the primary active transport of conjugated metabolites across the bile canalicular membrane: comparative study of S-(2,4-dinitrophenyl)-glutathione and 6-hydroxy-5,7-dimethyl-2-methylamino-4-(3-pyridylmethyl)benzothiazole glucuronide. XX-AUG-1997 30-AUG-2020
9103511 Multispecific organic anion transporter is responsible for the biliary excretion of the camptothecin derivative irinotecan and its metabolites in rats. XX-APR-1997 30-AUG-2020
11465411 Physicochemical parameters responsible for the affinity of methotrexate analogs for rat canalicular multispecific organic anion transporter (cMOAT/MRP2). XX-MAY-2001 30-AUG-2020
11961115 Expression and functional characterization of rat organic anion transporter 3 (rOat3) in the choroid plexus. XX-MAY-2002 30-AUG-2020
14675047 Characterization of uremic toxin transport by organic anion transporters in the kidney. XX-JAN-2004 29-AUG-2020
9464355 Novel potent nonpeptide aminopeptidase N inhibitors with a cyclic imide skeleton. 29-JAN-1998 22-AUG-2020
9873660 Preparation of biotinylated allosamidins with strong chitinase inhibitory activities. 03-NOV-1998 10-OCT-2018
9873473 Asymmetric synthesis of antimitotic combretadioxolane with potent antitumor activity against multi-drug resistant cells. 04-AUG-1998 09-OCT-2018
11861777 Functional involvement of rat organic anion transporter 3 (rOat3; Slc22a8) in the renal uptake of organic anions. 25-FEB-2002 22-MAY-2013
16610783 Practical synthesis and evaluation of the biological activities of 1alpha,25-dihydroxyvitamin D3 antagonists, 1alpha,25-dihydroxyvitamin D3-26,23-lactams. Designed on the basis of the helix 12-folding inhibition hypothesis. 13-APR-2006 20-MAY-2013
9756510 Reduced folate derivatives are endogenous substrates for cMOAT in rats. 23-NOV-1998 08-FEB-2013
9918561 Primary active transport of peptidic endothelin antagonists by rat hepatic canalicular membrane. 22-FEB-1999 08-FEB-2013
9495864 Carrier-mediated mechanism for the biliary excretion of the quinolone antibiotic grepafloxacin and its glucuronide in rats. 09-APR-1998 08-FEB-2013
18162399 SAR-oriented discovery of peroxisome proliferator-activated receptor pan agonist with a 4-adamantylphenyl group as a hydrophobic tail. 05-FEB-2008 15-DEC-2012
16617018 Diphenylmethane skeleton as a multi-template for nuclear receptor ligands: preparation of FXR and PPAR ligands. 08-MAY-2006 07-DEC-2012
10843222 Novel alpha-glucosidase inhibitors with a tetrachlorophthalimide skeleton. 02-OCT-2000 01-OCT-2012
10098663 Nonpeptide small-molecular inhibitors of dipeptidyl peptidase IV: N-phenylphthalimide analogs. 24-MAY-1999 30-SEP-2012
15901796 Bile salt export pump (BSEP/ABCB11) can transport a nonbile acid substrate, pravastatin. XX-XXX-2005 08-JUN-2012
17584609 Synthesis of unnatural flavonoids and stilbenes by exploiting the plant biosynthetic pathway in Escherichia coli. XX-JUN-2007 29-JUL-2011
9435893 Regulation of retinoidal actions by diazepinylbenzoic acids. Retinoid synergists which activate the RXR-RAR heterodimers. 13-FEB-1998 10-NOV-2009
9554881 Clarification of the binding mode of teleocidin and benzolactams to the Cys2 domain of protein kinase Cdelta by synthesis of hydrophobically modified, teleocidin-mimicking benzolactams and computational docking simulation. 21-MAY-1998 10-NOV-2009
10229620 Potent estrogenic agonists bearing dicarba-closo-dodecaborane as a hydrophobic pharmacophore. 03-JUN-1999 10-NOV-2009
10498208 Protein kinase C modulators bearing dicarba-CLOSO-dodecaborane as a hydrophobic pharmacophore. 28-OCT-1999 10-NOV-2009
10021922 Synthesis, computer modeling and biological evaluation of novel protein kinase C agonists based on a 7-membered lactam moiety. 11-MAY-1999 10-NOV-2009
10937721 Inhibition of dopamine receptors by endogenous amines: binding to striatal receptors and pharmacological effects on locomotor activity. 06-DEC-2000 10-NOV-2009
10636245 Role of the hydrophobic moiety of tumor promoters. Synthesis and activity of 2-alkylated benzolactams. 28-FEB-2000 10-NOV-2009
15050642 Parallel synthesis of DAPT derivatives and their gamma-secretase-inhibitory activity. 30-MAR-2004 10-NOV-2009
16682195 Novel gamma-secretase inhibitors discovered by library screening of in-house synthetic natural product intermediates. 05-JUN-2006 10-NOV-2009
15109656 Synthesis of 1alpha,25-dihydroxyvitamin D3-26,23-lactams (DLAMs), a novel series of 1 alpha,25-dihydroxyvitamin D3 antagonist. 27-APR-2004 10-NOV-2009
16766183 Synthesis of biotinylated photoaffinity probes based on arylsulfonamide gamma-secretase inhibitors. 04-AUG-2006 10-NOV-2009
16275077 Design and synthesis of substituted phenylpropanoic acid derivatives as human peroxisome proliferator-activated receptor alpha/delta dual agonists. 26-DEC-2005 10-NOV-2009
17532641 Design, synthesis, and evaluation of potent, structurally novel peroxisome proliferator-activated receptor (PPAR) delta-selective agonists. 12-JUN-2007 10-NOV-2009
17498949 Liver X receptor antagonists with a phthalimide skeleton derived from thalidomide-related glucosidase inhibitors. 22-JUN-2007 10-NOV-2009
18343126 Co-existence of alpha-glucosidase-inhibitory and liver X receptor-regulatory activities and their separation by structural development. 15-APR-2008 26-JUL-2008
17292610 Design, synthesis, and evaluation of non-steroidal farnesoid X receptor (FXR) antagonist. 01-APR-2007 29-APR-2008